Samsrita Labs (539267) Stock Overview
Operates as a biopharmaceutical company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
539267 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Samsrita Labs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹21.40 |
| 52 Week High | ₹26.04 |
| 52 Week Low | ₹12.19 |
| Beta | -0.027 |
| 1 Month Change | 2.29% |
| 3 Month Change | 9.18% |
| 1 Year Change | -3.47% |
| 3 Year Change | -26.46% |
| 5 Year Change | -55.56% |
| Change since IPO | 63.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539267 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -2.1% | 1.0% | 0.4% |
| 1Y | -3.5% | -4.9% | 1.7% |
Return vs Industry: 539267 underperformed the Indian Life Sciences industry which returned -2.2% over the past year.
Return vs Market: 539267 underperformed the Indian Market which returned 2.5% over the past year.
Price Volatility
| 539267 volatility | |
|---|---|
| 539267 Average Weekly Movement | 10.2% |
| Life Sciences Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: 539267's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 539267's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 4 | n/a | drhlsl.com |
Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research and therapy, including regenerative medicine, bio-artificial organ scaffold development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology for the body organs of the liver, pancreas, neural, cardiac, vascular, renal, and orthopedic systems.
Samsrita Labs Limited Fundamentals Summary
| 539267 fundamental statistics | |
|---|---|
| Market cap | ₹486.84m |
| Earnings (TTM) | -₹47.57m |
| Revenue (TTM) | n/a |
Is 539267 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539267 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹47.57m |
| Earnings | -₹47.57m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.09 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 10.8% |
How did 539267 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 04:08 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Samsrita Labs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.